Atıf İçin Kopyala
Robson J. C., Tomasson G., Milman N., Ashdown S., Boonen A., Casey G. C., ...Daha Fazla
JOURNAL OF RHEUMATOLOGY, cilt.44, sa.10, ss.1529-1535, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
44
Sayı:
10
-
Basım Tarihi:
2017
-
Doi Numarası:
10.3899/jrheum.161139
-
Dergi Adı:
JOURNAL OF RHEUMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1529-1535
-
Anahtar Kelimeler:
ANCA-ASSOCIATED VASCULITIS, PATIENT-REPORTED OUTCOMES, PROMIS, ICF, OMERACT, QUALITY-OF-LIFE, ANCA-ASSOCIATED VASCULITIS, WEGENERS-GRANULOMATOSIS, CLINICAL-TRIALS, CORE SET, INVOLVEMENT
-
Marmara Üniversitesi Adresli:
Evet
Özet
Objective. The antineutrophil cytoplasmic antibody-associated vasculitides (AAV) are multiorgan diseases. Patients with AAV report impairment in their health-related quality of life (HRQOL) and have different priorities regarding disease assessment compared with physicians. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group previously received endorsement for a core set of domains in AAV. Two approaches to measure patient-reported outcomes (PRO) were presented at OMERACT 2016.